The Food and Drug Administration has warned that gadolinium-based contrast agents used during an MRI (Magnetic Resonance Imaging) or MRA (Magnetic Resonance Angiography) can stay in the body, including the brain, for months to years following an MRI or MRA. Many patients undergoing MRIs or MRAs are injected with gadolinium-based contrast agents or dyes containing the heavy metal. They are used to enhance the image of internal organs, tissues and blood vessels during MRAs or MRIs.
Gadolinium-based dyes or contrast agents that stay in the body for extended periods of time can cause serious health problems on the body and brain of patients. The FDA has required manufacturers to add warning labels to gadolinium-based contrast agents to warn patients of the potential risks.
In patients with normal kidney function, the retention of gadolinium in the body after an MIR or MRA can be linked to Gadolinium Deposition Disease (GDD). GDD is a condition that involves bone pain, burning tissue pain and cognitive effects such as memory impairment and persistent headaches. Gadolinium storage condition involves excess amounts of gadolinium in the body. The FDA has warned doctors to minimize repeated MRIs used gadolinium contrast agents when possible.
If you or someone you love suffered gadolinium related injuries following an MRI or MRA, you must act quickly to get the compensation you deserve. Contact our law firm today, and we’ll get started on your case immediately. There’s no cost or obligation, and you won’t pay us anything unless you recover compensation.
This law firm is not associated with, sponsored by, or affiliated with the FDA. Cases may be referred to associated law firms.